Company: XTIA
Filing Date: 2025-06-20
Form Type: S-1/A
Source: 0001213900-25-055855
Chunk: 34

Company: XTI Aerospace, Inc.
Filing Date: 2025-06-20
Form: S-1/A
Chunk 34
---
.30 per share and the dilution to new investors purchasing
shares in this Offering by $0.70 per share, assuming the number of shares offered by us, as set forth on the cover page of this prospectus,
remains the same, and after deducting estimated underwriting discounts and commissions. An increase (decrease) of 1,000,000 shares in
the number of shares offered by us, as set forth on the cover page of this prospectus, would increase (decrease) the pro forma as adjusted
net tangible book value after this Offering by $0.11 per share and decrease the dilution to new investors purchasing shares of our common
stock in this Offering by $0.11 per share, assuming no change in the assumed public offering price of $3.51 per share and accompanying
Common Warrant and after deducting estimated underwriting discounts and commissions.

<div align='center'>18</div>

If the underwriters exercise
their option to purchase additional shares and/or Pre-funded Warrants and/or additional Common Warrants in full, the pro forma as adjusted
net tangible book value per share after giving effect to the Offering would be $1.69 per share. This represents an immediate increase
in pro forma as adjusted net tangible book value of $0.82 per share to existing stockholders and immediate dilution of $1.82 per share
to new investors purchasing our common stock in this Offering.

The information discussed
above is illustrative only and will adjust based on the actual public offering price, the actual number of shares of common stock that
we offer in this Offering, and other terms of this Offering determined at the time of pricing. The foregoing discussion and table assume
(i) no issuance of Pre-funded Warrants, which if sold, would reduce the number of shares of common stock that we are offering on a one-for-one
basis and (ii) no exercise of the Representative’s Warrants to be issued in this Offering. In addition, we may choose to raise
additional capital due to market conditions or strategic considerations. To the extent that additional capital is raised through the
sale of equity or convertible debt securities, the issuance of these securities could result in further dilution to our stockholders.

The number of shares of
common stock outstanding set forth in the table above excludes, as of March 31, 2025:

| ● | 50,333 shares of common stock issuable upon the exercise of outstanding stock options, at a weighted average exercise price